ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,010.60
      0.87%
      US Tech 100
      16,831.20
      0.47%
      Dow Jones
      38,239.98
      0.67%
      Brent Oil
      85.885
      -0.61%
      Bitcoin
      66,111.32
      -1.11%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Achilles Therapeutics PLC (ACHL)

      7. Achilles Therapeutics PLC (ACHL) News

      ACHL Achilles Therapeutics PLC

      0.79
      0.00 (0.00%)
      Pre Market
      Last Updated: 04:16:33
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Achilles Therapeutics PLC ACHL NASDAQ Depository Receipt
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.00 0.00% 0.79 04:16:33
      Open Price Low Price High Price Close Price Prev Close
      0.79
      more quote information »

      Recent News

      Date Time Source Heading
      4/22/20248:49IHNWFeaturedCannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California
      4/04/202406:45GLOBEAchilles Therapeutics Reports Fourth Quarter and Year-End..
      4/04/202406:30GLOBEAchilles Therapeutics Provides Interim Phase I/IIa Update on..
      2/05/202407:00GLOBEAchilles Therapeutics to Present at the 10th Annual..
      2/01/202413:14EDGAR2Form 144 - Report of proposed sale of securities
      12/18/202307:00GLOBEAchilles Therapeutics Announces Publication of Nature Cancer..
      11/13/202316:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      11/13/202316:30GLOBEAchilles Therapeutics Reports Third Quarter 2023 Financial..
      11/01/202317:26EDGAR2Form 144 - Report of proposed sale of securities
      9/22/202316:42EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      9/22/202316:30GLOBEAchilles Therapeutics Receives Nasdaq Deficiency Notice..
      9/20/202308:45IHNWPathways to Progress: How Orphan Drug Designation Sparks..
      8/17/202315:16EDGAR2Form 144 - Report of proposed sale of securities
      8/04/202307:42EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      8/04/202307:00GLOBEAchilles Therapeutics Reports Second Quarter 2023 Financial..
      6/29/202316:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      6/12/202308:00GLOBEAchilles Therapeutics to Present at Upcoming Conferences
      5/10/202307:15GLOBEAchilles Therapeutics Reports First Quarter 2023 Financial..
      5/10/202307:00GLOBEAchilles Therapeutics’ New Immunogenicity Prediction..
      4/25/202318:00GLOBEAchilles Therapeutics Receives Nasdaq Deficiency Notice..
      4/25/202307:00GLOBEAchilles Therapeutics Announces Grant of US Patent Covering..

      Your Recent History

      NASDAQ
      ACHL
      Achilles Therapeutics
      Delayed Upgrade Clock